A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

Also called NCT06676072

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 188 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06676072
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Austria, Lithuania, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06676072. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-22 (actual); primary completion 2026-04-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
Acronym
FlexPulse IDE
Condition
Atrial Fibrillation (AF)
Condition
Atrial Arrhythmia
Condition
Paroxysmal AF
Condition
Drug Refractory Paroxysmal Atrial Fibrillation
Intervention (Device)
PFA Ablation catheter
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06676072
Content hash
859ad9ed5b6faa89d84bc39c3e30469676ab2ee325a58b77e7119c530182f876